Cabaletta Bio
NASDAQ: CABARadnor, US · Founded 2017 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MS
Mark SimonDirector
SN
Steven NichtbergerExecutive Officer, Director
DG
Dan GeffkenExecutive Officer
BD
Brian DanielsDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$50MraisedJan 2019 · 16 investors · BiotechnologyRule 506(b)
▶$50MraisedJan 2019 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven NichtbergerExecutive Officer, Director
- Mark SimonDirector
- Brian DanielsDirector
- Dan GeffkenExecutive Officer
- Amount sold
- $50M
- Sales commissions
- $1.1M
- Placement agents
- Cowen and Company, LLC
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$38.3MraisedDec 2018 · 11 investors · BiotechnologyRule 506(b)
▶$38.3MraisedDec 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark SimonDirector
- Steven NichtbergerExecutive Officer, Director
- Brian DanielsDirector
- Dan GeffkenExecutive Officer
- Amount sold
- $38.3M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.